Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AxoGen ( (AXGN) ) has shared an announcement.
On August 5, 2025, Axogen, Inc. reported its financial results for the second quarter of 2025, showcasing a significant revenue increase of 18.3% compared to the same period in 2024. The company also raised its full-year revenue guidance to at least 17% growth, or $219 million, reflecting strong market development strategies and commercial execution. The quarter saw broad-based revenue growth across all markets, including Extremities, Oral Maxillofacial & Head and Neck, and Breast. Additionally, Axogen expanded coverage and reimbursement for nerve repair, adding approximately 10 million new covered lives in 2025. The U.S. FDA accepted the company’s Biologics License Application for Avance® Nerve Graft, with a goal date for approval set for September 5, 2025.
The most recent analyst rating on (AXGN) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on AxoGen stock, see the AXGN Stock Forecast page.
Spark’s Take on AXGN Stock
According to Spark, TipRanks’ AI Analyst, AXGN is a Neutral.
AxoGen’s overall stock score reflects strong revenue growth and strategic advancements, offset by ongoing profitability challenges and valuation concerns. Technical indicators provide a moderate positive outlook, though overbought conditions warrant caution.
To see Spark’s full report on AXGN stock, click here.
More about AxoGen
Axogen, Inc. is a leading company in the field of peripheral nerve regeneration and repair, focusing on the development and commercialization of innovative surgical solutions. Their product portfolio includes the Avance® Nerve Graft and various Axoguard products, which are designed to aid in the repair and protection of peripheral nerves. Axogen’s products are available in multiple countries, including the United States, Canada, and several European and Asian nations.
Average Trading Volume: 947,883
Technical Sentiment Signal: Hold
Current Market Cap: $577M
For detailed information about AXGN stock, go to TipRanks’ Stock Analysis page.